https://www.law360.com/lifesciences?utm_source=rss&utm_medium=rss&utm_campaign=section Latest articles for: Life Sciences Copyright 2025 Portfolio Media, Inc. en-US Thu, 01 May 2025 21:59:22 +0000 https://www.law360.com/lifesciences/articles/2332927?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2332927 The U.S. Department of Health and Human Services on Thursday released a report it says raises "serious concerns" about medical interventions used to aid young people in gender transition. Thu, 01 May 2025 20:46:31 +0000 https://www.law360.com/lifesciences/articles/2332772?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2332772 The Federal Circuit's argument calendar for May includes appeals of two nine-figure patent verdicts — one against Apple and one against Medtronic — and Roku's bid to revive its remote control patent suit at the U.S. International Trade Commission after a loss tied to the commission's domestic industry requirement. Thu, 01 May 2025 20:10:26 +0000 https://www.law360.com/lifesciences/articles/2332952?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2332952 A Georgia jury heard in closing arguments on Thursday that C.R. Bard's medical sterilization plant wantonly polluted the air with ethylene oxide and caused a man's cancer, while the company said the man's exposure was nowhere near danger levels. Thu, 01 May 2025 19:43:26 +0000 https://www.law360.com/lifesciences/articles/2333310?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2333310 The Eleventh Circuit held Thursday that a couple's lawsuit against Johnson & Johnson over injuries allegedly caused by a pelvic mesh device made by the company's med-tech unit was filed too late despite evidence that the woman's doctors had expressed uncertainty for years about whether the mesh was causing her pain. Thu, 01 May 2025 19:25:35 +0000 https://www.law360.com/lifesciences/articles/2332580?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2332580 Publix Super Markets Inc. can't slip opioid-related claims from nine municipalities in which the supermarket chain alleges it has no pharmacies, an Ohio federal judge overseeing sprawling national opioid litigation ruled. Thu, 01 May 2025 19:03:52 +0000 https://www.law360.com/lifesciences/articles/2333001?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2333001 Express Scripts and Prime Therapeutics urged the Sixth Circuit to undo a district court order returning a lawsuit from Ohio's attorney general alleging they drove up prescription drug prices to state court, arguing Wednesday an after-the-fact disclaimer of federal program-based claims isn't enough to sever a federal law connection. Thu, 01 May 2025 18:59:04 +0000 https://www.law360.com/lifesciences/articles/2332720?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2332720 U.S. Sens. Thom Tillis and Chris Coons on Thursday brought back two significant patent reform bills from last term that overall aim to make invalidating patents more difficult. Thu, 01 May 2025 18:11:23 +0000 https://www.law360.com/lifesciences/articles/2332748?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2332748 The Justice Department is urging the U.S. Supreme Court to reject a petition over the eligibility of telemedicine patents it's accused of infringing, but it said that if the petition is granted, it plans to argue the patents shouldn't have been invalidated as abstract. Thu, 01 May 2025 17:50:08 +0000 https://www.law360.com/lifesciences/articles/2333074?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2333074 A Johnson & Johnson talc unit has asked a New Jersey federal court to reinstate its libel suit over a scientific article linking talcum powder to mesothelioma, arguing that newly discovered evidence shows statements in the article are false. Thu, 01 May 2025 17:35:20 +0000 https://www.law360.com/lifesciences/articles/2333079?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2333079 A Connecticut federal judge on Thursday refused to put a bow on the deal the state of Florida struck with Sandoz AG and related defendants in three generic drug price-fixing lawsuits, ruling from the bench in Hartford that the settlement agreement "as written" would lead to exorbitant supplemental payments in the event that other states also reach deals to release their claims. Thu, 01 May 2025 16:26:00 +0000 https://www.law360.com/lifesciences/articles/2331854?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2331854 A Texas bankruptcy court recently rejected Johnson & Johnson's third attempt to use Chapter 11 to resolve liabilities from allegations of injuries from using talcum powder, suggesting that the U.S. Supreme Court's limitations on nondebtor releases, from 2024's Purdue Pharma ruling, may prove difficult to evade, say attorneys at Cadwalader. Thu, 01 May 2025 16:14:37 +0000 https://www.law360.com/lifesciences/articles/2333012?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2333012 The legal malpractice suit in which gene sequencing company GenapSys Inc. argued Paul Hastings LLP caused GenapSys' bankruptcy appears to have been settled. Thu, 01 May 2025 14:58:54 +0000 https://www.law360.com/lifesciences/articles/2332637?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2332637 A former McCarter & English LLP client waited too long to challenge interest calculations that added more than $1 million to an attorney fee award, the firm has argued, asking a judge to reject Jarrow Formulas Inc.'s bid to reduce a March 12 judgment totaling $3.8 million. Thu, 01 May 2025 10:21:44 +0000 https://www.law360.com/lifesciences/articles/2305667?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2305667 Serving as an adjunct college professor has taught me the importance of building rapport, communicating effectively, and persuading individuals to critically analyze the difference between what they think and what they know — principles that have helped to improve my practice of law, says Sheria Clarke at Nelson Mullins. Wed, 30 Apr 2025 22:57:06 +0000 https://www.law360.com/lifesciences/articles/2332572?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2332572 A Maryland federal judge has certified 10 classes of customers who bought a knockoff version of a proprietary probiotic formula developed by a professor to treat gastrointestinal ailments, saying in an order unsealed Wednesday the customers all suffered the same alleged injury from buying a product that wasn't the one they expected.  Wed, 30 Apr 2025 22:52:11 +0000 https://www.law360.com/lifesciences/articles/2331189?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2331189 Spring has sprung for appellate arguments over the White House's pruning and shearing of agencies, part of a bountiful circuit calendar in May, when appeals courts will also tend to defamation drama involving a pro golfer, antitrust suits against drugmakers and hotels, and a nine-figure patent verdict against Apple Inc. Wed, 30 Apr 2025 22:33:42 +0000 https://www.law360.com/lifesciences/articles/2332615?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2332615 Nationwide has filed suit asking an Illinois federal court to declare that it has no duty to cover a suburban Chicago gym in a 3-year-old "fat freezing" injury case headed to trial in June, saying the underlying injury doesn't trigger the facility's policy. Wed, 30 Apr 2025 22:31:16 +0000 https://www.law360.com/lifesciences/articles/2332654?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2332654 The chief judge for the Delaware federal court has turned down a bid from Pfizer and BioNTech to invalidate patent claims asserted against their blockbuster COVID-19 vaccine, in a case set to go before a jury later this year. Wed, 30 Apr 2025 22:06:13 +0000 https://www.law360.com/lifesciences/articles/2332079?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2332079 A Delaware federal judge has shot down MSN Pharmaceuticals Inc.'s attempt to get its generic version of Novartis' blockbuster cardiovascular drug Entresto on the market immediately by removing the branded-drug maker's patent from a federal database. Wed, 30 Apr 2025 21:32:20 +0000 https://www.law360.com/lifesciences/articles/2332450?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2332450 A consumer is asking a New York federal judge to dismiss his proposed class action accusing Onnit Labs Inc. of falsely advertising its "Alpha Brain" cognitive supplement, which were previously promoted by podcaster Joe Rogan, as clinically proven to boost memory.